Managing the Interplay of Familial Hypercholesterolemia and COVID-19
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Metabolic
Semaglutide Injection Now Available as a Single Pen for Monthly Therapy
Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins.
Cardiovascular Risk Management in Rheumatoid Arthritis
Researchers estimated cardiovascular risk by different strategies in patients with RA; analyzed the percentage of patients who would be candidates to receive statin therapy; and identified how many patients met the recommended lipid goals.
Machine Learning With Novel Lipid Parameters Improved FH Classification
Machine learning was used to develop a model incorporating multiple biomarkers that improved the classification of familial hypercholesterolemia.
Review Examines Cardiovascular Side Effects of Second-Generation Antipsychotics
A systematic review examined the metabolic and cardiovascular adverse effects in commonly prescribed second-generation antipsychotics.
Alirocumab Approved for Homozygous Familial Hypercholesterolemia
The approval was based on data from the phase 3 ODYSSEY HoFH trial, which evaluated Praluent in 69 adults with HoFH who were on other LDL-C-lowering therapies.
USPSTF Urges Prediabetes, T2DM Screen for Overweight Adults
The U.S. Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in overweight or obese adults.
Distinct Metabolic Phenotypes Affect Stable Chest Pain Outcomes
Patients with stable chest pain had four distinct patterns of metabolic phenotypes which had unique coronary artery disease trajectories and major adverse cardiovascular event risk profiles.
Polynesian Ancestry May Increase Cardiometabolic Risk
Polynesian ancestry in Native Hawaiians seems to be associated with an increased risk for obesity, type 2 diabetes.
Primary Care Lifestyle Intervention Has Cardiometabolic Benefits
Lifestyle intervention results in significantly more weight loss and in improved fasting glucose, HDL-cholesterol.
-
Loading...
-
Loading...
